ClinicalTrials.gg
RecruitingNCT07706192Updated Jul 15, 2026

Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts

An interventional study of Food Assistance Program and Standard of Care in Treatment Adherence, sponsored by Virginia Commonwealth University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
350
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.

Planned enrollment
6th of 70
350 · median 66
Started
2026
with 4 others
No phase
58 of 75
8 open now
Primary completion
2035-08
later than 14 of 14 live
Registered
72nd of 75
by date

Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 6th largest by planned enrollment of the 70 interventional ones that give a count, is one of 5 that started in 2026, is one of 58 with no phase, reaches primary completion later than 14 of the 14 other live ones, and was the 72nd registered.

Treatment Adherence and Compliance

353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.

Browse Treatment Adherence and Compliance studies →

Open to participants now

12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Treatment Adherence and Compliance with a site in United States, or all of them as a file.
02

Study summary

Prospective cohort and descriptive study aimed at identifying cancer patients experiencing food insecurity at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center. The study will involve evaluating the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.

03

Conditions studied

  • Treatment Adherence

Keywords

  • Treatment Adherence
  • Food Insecurity
  • Cancer Patients on Active Treatment
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years old) with a current diagnosis of cancer
  • Patients attending outpatient services at the VCU Massey Comprehensive Cancer Center
  • Patients who are willing to participate and provide
  • Responding "sometimes true" or "often true" to at least one of the two validate Hunger Vital Sign Screening questions

Exclusion criteria

Exclusion Criteria:

  • Patients who are unable to provide due to cognitive impairment or language barriers
  • Patients who are enrolled in other clinical trials that prohibit participation in additional research
  • Patients who do not consent to being included in the food insecurity registry
  • Patients with medical conditions other than cancer
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
350 participants (estimated)

Study arms

  • Experimental
    Food Assistance Program

    Six month food assistance program-shelf-stable food boxes

    Other: Food Assistance Program

  • Active comparator
    Standard of Care

    Usual-care referrals

    Other: Standard of Care

Interventions

  • OtherFood Assistance Program

    Participants will be enrolled and provided with structured food assistance (e.g., shelf stable food boxes, produce vouchers) for six months

    Also known as: Intervention Cohort

  • OtherStandard of Care

    Participants who receive usual-care referrals but not food packages.

    Also known as: Comparison Cohort

06

What researchers measure

Primary outcomes

  1. Evaluate the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.

    Percent of participants that self-report of treatment completion

    Time frame: 6 months following enrollment

Secondary outcomes

  1. Change in Food Insecurity Score

    Using the Food Insecurity Assessment: a 2 Question Hunger Vital Signs will be used to assess patient food insecurity status with the following two questions: "Within the past 12 months, did you worry your food would run out before you got the money to buy more?" "Within the past 12 months, did the food you buy not last and you didn't have money to get more?" Scoring will categorize patients as never true, sometimes true, or often true. Baseline is defined as when a patient responds SOMETIMES TRUE or OFTEN TRUE to one of the two validated Hunger Vital Sign Screening questions for the first time. Patients will receive an email about the financial impact and QOL validated surveys at each time interval.

    Time frame: Baseline and 6 month follow-up

  2. Change in Quality of Life (QOL) using European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-30)

    The EORTC QLQ-30 questionnaire is a 30-item, patient-reported instrument designed to assess the health-related quality of life (HRQoL), functional status, and symptom burden of cancer patients. Comprises 30 questions grouped into 5 functional scales, 9 symptom scales/items, and a global health status. Scoring: Uses a 4-point Likert scale (7-point for global items), transformed to a 0-100 scale. Higher scores indicate better function/QoL, but worse symptom burden.

    Time frame: Baseline and 6 month follow-up

  3. Change in financial toxicity

    The Functional Assessment of Chronic Illness Therapy for measure of financial toxicity (FACIT-COST) questionnaire to assess the impact of treatment on patient financial status. This measure has 12 questions based on patient reported outcomes to assess financial quality of life stress; numeric responses 0-4; Uses a score range 0-44 with higher scores indicating better Financial Well-Being.

    Time frame: Baseline and 6 month follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There are no current plans to share individual patient data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Aug 2035, 109 months after the start.

Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 109 months is above that.

Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 15, 2026
StartActual
Jul 6, 2026
Primary completionEst.
Aug 31, 2035
CompletionEst.
Aug 31, 2035
Last update
Jul 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07706192
Responsible party
Sponsor
First posted
Jul 15, 2026
Start date
Jul 6, 2026
Primary completion
Aug 31, 2035 (estimated)
Completion
Aug 31, 2035 (estimated)
Last update
Jul 15, 2026

Study contacts

Massey CTO CPC Team
Contact
MasseyCPC@vcu.edu
804-628-6430
Susan Hong, MD
principal investigator · Virginia Commonwealth University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion